Skip to main content



Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand

  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    L04: EP-104IAR (Extended-Release Fluticasone Propionate for Injectable Suspension): Topline and Key Secondary Results from a Phase 2 Randomized, Double-blind, Vehicle-Controlled Trial in Subjects with Knee Osteoarthritis
    Location: Poster Hall
    Late-Breaking Poster Presenter: Amanda M. Malone, PhD – Eupraxia Pharmaceuticals
    Osteoarthritis and related disorders
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    L05: DICKENS: A Multicentre Randomised Controlled Trial of Diacerein for Knee Osteoarthritis with Effusion-Synovitis
    Location: Poster Hall
    Late-Breaking Poster Presenter: Guoqi Cai, PhD, MMed – School of Public Health, Anhui Medical University
    Osteoarthritis and related disorders
  • Tuesday, Nov 14th
    2:15 PM – 2:25 PM PT
    2498: Does Physical Activity Modify the Relationship Between Pain and Corticosteroid Injection Utilization in Adults with or at High Risk for Knee Osteoarthritis?
    Location: Room 24A-C
    Presenting Author: Sydney Liles, DPT – University of Delaware
    Osteoarthritis and related disorders
  • Wednesday, Nov 15th
    8:30 AM – 8:45 AM PT
    L19: A Phase 3 Study of Repeat Injection of TLC599 in Osteoarthritis of the Knee: Benefits to 52 Weeks
    Location: Room 6A-B
    Presenting Author: David Hunter, PhD, MBBS, FRACP – Sydney Musculoskeletal Health, University of Sydney
    Osteoarthritis and related disorders